Top

Journal of Gastrointestinal Surgery

Published in:

01-02-2008

Prognostic Factors and Recurrence of Small Hepatocellular Carcinoma after Hepatic Resection or Microwave Ablation: A Retrospective Study

Authors: Zhi Li Wang, Ping Liang, Bao Wei Dong, Xiao Ling Yu, De Jiang Yu

Published in: Journal of Gastrointestinal Surgery | Issue 2/2008

Abstract

Purpose

This study aims to analyze the long-term therapeutic results of small HCC less than 5 cm in diameter after microwave ablation (MA) or hepatic resection (HR) and choose factors that could predict metastasis and recurrence of small HCC.

Materials and Methods

The metastasis and recurrence of 194 patients with one HCC less than 5 cm in diameter who underwent curative HR or MA between January 1995 and December 2004 were reviewed retrospectively; immunohistochemistry was used to analyze the expressions of VEGF, bFGF, and c-Met in HCC tissues. Posttreatment prognostic factors were evaluated by multivariate analysis using Cox’s proportional hazards model. The variables included the expressions of these three proteins in HCC tissues, the clinical and pathologic characteristics of the patients.

Results

The retrospective study showed that 1-, 3-, and 5-year disease-free survival rates of patients with single HCC of diameter <5 cm were 71.3, 57.0 and 32.5%, respectively. Furthermore, 1-, 3-, and 5-year disease-free survival rates of the patients in MA group and resection group were 72.8, 54.0 and 33.0%; 68.5, 60.0, and 25.6%, respectively. There was no significant difference in disease-free survival rates between these two groups. The result of multivariate analysis showed that differentiation degree of HCC and the expressions of VEGF and c-Met in HCC tissues could be as the independent prognostic factors affecting metastasis and recurrence in patients with small HCC, whereas the methods of therapy had no impact on prognosis.

Conclusions

The metastasis and recurrence rate after MA is similar to that after HR, and the methods of therapy do not affect the prognosis of small HCC. The metastasis and recurrence of patients with small HCC will differ depending on tumor differentiation, expressions of VEGF and c-Met in HCC tissues.

Nagashima I, Hamada C, Naruse K, Osada T, Nagao T, Muto T. Surgical resection for small hepatocellular carcinoma. Surgery 1996;119:40–45.PubMedCrossRef

Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S. Surgery for small liver cancers. Semin Surg Oncol 1993;9:298–304.PubMedCrossRef

Yamasaki S, Hasegawa H, Makuuchi M, Takayama T, Kosuge T, Shimada K. Choice of treatment for small hepatocellular carcinoma: hepatectomy, embolization or ethanol injection. J Gastroenterol Hepatol 1991;6:408–413.PubMed

Dong BW, Liang P, Yu XL, Zeng XQ, Wang PJ, Su L, Wang XD, Xin H, Li S. Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study. AJR 1998;171:449–454.PubMed

Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996;334:1561–1567.PubMedCrossRef

Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial. Lancet 2000;356:802–807.PubMedCrossRef

Chen YJ, Ye SH, Chen JT, Wu CC, Hsu MT, Tsai SF, Chen PJ, Lin CH. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 2000;119:431–440.PubMedCrossRef

Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994;106:1618–1624.PubMed

Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434–1440.PubMedCrossRef

10.

Mattern J, Koomagi R, Volm M. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res 1997;17:2249–2252.PubMed

11.

Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer 1997;74:64–68.PubMedCrossRef

12.

Compagni A, Wilgenbus P, Impagnatiello MA, Cotten M, Christofori G. Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res 2000;60:7163–7169.PubMed

13.

Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002;8:385–392.PubMed

14.

Horiguchi N, Takayama H, Toyoda M, Otsuka T, Fukusato T, Merlino G, Takaqi H, Mori M. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene 2002;21:1791–1799.PubMedCrossRef

15.

Okada S. Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis 1999;19:323–328.PubMedCrossRef

16.

Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999;229:216–222.PubMedCrossRef

17.

Shimoyawa N, Hanayaki K. Long-term prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 2004;198:356–365.CrossRef

18.

Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10–24.PubMedCrossRef

19.

Mise M, Arii S, Higashituji H, Furutani M, Niwano M, Harada T, Ishigami S, Toda Y, Nakayama H, Fukumoto M, Fujita J, Imamura M. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 1996;23:455–464.PubMedCrossRef

20.

Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R. Role of the hepatocyte growth factors receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 2002;13:41–59.PubMedCrossRef

21.

Saftoiu A, Ciurea T, Banita M, Georgescu C, Comanescu V, Rogoveanu I, Gorunescu F, Georfescu I. Immunohistochemical assessment of angiogenesis in primary hepatocellular carcinoma. Rom J Gastroenterol 2004;13:3–8.PubMed

22.

Chow NH, Cheng KS, Lin PW, Chan SH, Su WC, Sun YN, Lin XZ. Expression of fibroblast growth factor-1 and fibroblast growth factor-2 in normal liver and hepatocellular carcinoma. Dig Dis Sci 1998;43:2261–2266.PubMedCrossRef

23.

Okano J, Shiota G, Kawasaki H. Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver disease: and immunohistochemical study. Liver 1999;19:151–159.PubMedCrossRef

24.

Okada S. Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis 1999;19:323–328.PubMed

25.

Botha JF, Langnas AN. Liver transplantation for hepatocellular carcinoma: an update. J Natl Compr Canc Netw 2006;4:762–767.PubMed

26.

Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005;235:299–307.PubMedCrossRef

27.

Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, Sato M, Uchiyama S, Inoue K. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817–825.PubMedCrossRef

28.

Midorikawa T, Kumada K, Kikuchi H, Ishibashi K, Yagi H, Nagasaki H, Nemoto H, Saitoh M, Nakano H, Yamaguchi M, Koh Y, Sakai H, Yoshiyawa Y, Sanada Y, Yoshiba M. Microwave coagulation therapy for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2000;7:252–259.PubMedCrossRef

29.

Asahara T, Nakahara H, Fukuda T, Nakatani T, Yano M, Hino H, Okamoto Y, Katayama K, Itamoto T, Ono E, Dohi K, Kitamoto M, Nakanishi T. Percutaneous microwave coagulation therapy for hepatocellular carcinoma. Hiroshima J Med Sci 1998;47:151–155.PubMed

30.

Shimada S, Hirota M, Beppu T, Matsuda T, Hayashi N, Tashima S, Takai E, Yamaguchi K, Inoue K, Ogawa M. Complications and management of microwave coagulation therapy for primary and metastatic liver tumors. Surg Today 1998;28:1130–1137.PubMedCrossRef

31.

Solbiati L, Tonolini M, Cova L. Monitoring RF ablation. Eur Radiol 2004;14(suppl 8):34–42.

32.

Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, Kojiro M. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 2003;26:142–147.PubMedCrossRef

33.

Yoshiji H, Kuriyama S, Yoshii J, Yamazaki M, Kikukawa M, Tsujinoue H, Nakatani T, Fukui H. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells. Hepatology 1998;28:1489–1496.PubMedCrossRef

34.

Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 1997;25:862–866.PubMedCrossRef

35.

Poon RT, Ng IOL, Lau C, Yu WC, Fan ST, Wong J. Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma. Am Surg 2001;182:298–304.CrossRef

Title: Prognostic Factors and Recurrence of Small Hepatocellular Carcinoma after Hepatic Resection or Microwave Ablation: A Retrospective Study
Authors: Zhi Li Wang
Ping Liang
Bao Wei Dong
Xiao Ling Yu
De Jiang Yu
Publication date: 01-02-2008
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 2/2008
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-007-0310-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prognostic Factors and Recurrence of Small Hepatocellular Carcinoma after Hepatic Resection or Microwave Ablation: A Retrospective Study

Abstract

Purpose

Materials and Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Materials and Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2008

PGE2 in Pancreatic Cyst Fluid Helps Differentiate IPMN from MCN and Predict IPMN Dysplasia

Duodenojejunostomy Leaks After Pancreaticoduodenectomy

What to Expect in the Excluded Stomach Mucosa After Vertical Banded Roux-en-Y Gastric Bypass for Morbid Obesity

FLS Assessment of Competency Using Simulated Laparoscopic Tasks

Pancreatic VIPomas: Subject Review and One Institutional Experience

Catastrophic Clostridium difficile Enteritis in a Pelvic Pouch Patient: Report of a Case